Key facts
- AlterDiag’s last known valuation is $4.8M (Jan 2025).
- It has raised $2.1M; the latest was Seed Round ($2.1M) in Jan 2025.
- Notable investors include Forepont Capital Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for AlterDiag
- ·The full record, as it builds
Funding rounds
No funding rounds for AlterDiag are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AlterDiag
Manufacturer of a rapid diagnostic tools intended to provide fast and cost-effective diagnostic tools for healthcare professionals and patients. The company offers easy-to-use tests for healthcare centers and home use, enabling healthcare providers and patients to access personalized care and respond swiftly to medical needs.
- Sector
- Healthcare
- HQ
- Clermont-Ferrand, France
- Founded
- 2024
- Employees
- 3
- Website
- alterdiag.com/
- Ownership
- Privately Held (backing)
AlterDiag doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AlterDiag shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AlterDiag in its N-PORT filings yet. We sweep new filings monthly.